Investors
List of the current and past investors into BioRelix Inc with their respective financial instruments.Investor | Profile | Country | Phone | Round | |||
---|---|---|---|---|---|---|---|
![]() |
Aisling Capital | United States | +1 (212) 651-6380 | Series A | |||
![]() |
Alexandria Real Estate Equities Inc | United States | +1 (626) 578-0777 | Seed | |||
![]() |
Alexandria Real Estate Equities Inc | United States | 6265780777 | Seed | |||
![]() |
Alexandria Real Estate Equities Inc | United States | (626) 578-0777 | Seed | |||
![]() |
Alexandria Real Estate Equities Inc | United States | +1 (626) 578-0777 | Series A | |||
![]() |
Alexandria Real Estate Equities Inc | United States | 6265780777 | Series A | |||
![]() |
Alexandria Real Estate Equities Inc | United States | (626) 578-0777 | Series A | |||
Brian Dixon | Individual investor. | N/A | |||||
![]() |
CHL Medical Partners | Venture capital firm focused on early-stage healthcare sectors. | United States | +1 (203) 324-7700 | Seed | ||
![]() |
CHL Medical Partners | Venture capital firm focused on early-stage healthcare sectors. | United States | +1 (203) 324-7700 | Series A | ||
![]() |
Connecticut Innovations Inc (CI) | United States | +1 (860) 563-5851 | N/A | |||
![]() |
Elm Street Ventures | United States | +1 (203) 401-4201 | Series A | |||
![]() |
Elm Street Ventures | United States | +1 (203) 401-4201 | Seed | |||
![]() |
New Leaf Venture Partners (NLV) | United States | +1 (646) 871-6400 | Series A | |||
![]() |
New Leaf Venture Partners (NLV) | United States | +1 (646) 871-6400 | N/A | |||
![]() |
Novartis Venture Funds | The corporate venturing arm of Novartis. | Switzerland | +41 (61) 324-6210 | Series A | ||
![]() |
Novartis Venture Funds | The corporate venturing arm of Novartis. | Switzerland | +41 (61) 324-6210 | Seed | ||
![]() |
Novartis Venture Funds | The corporate venturing arm of Novartis. | Switzerland | +41 (61) 324-6210 | N/A | ||
![]() |
OpGen Inc | Provider of Whole Genome Mapping technologies for high-precision microbial analysis markets. | United States | N/A |